Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers

Gustavo Arango-Argoty, Elly Kipkogei, Ross Stewart, Arijit Patra, Ioannis Kagiampakis, Etai Jacob
doi: https://doi.org/10.1101/2023.09.12.23295357

Article Information

doi 
https://doi.org/10.1101/2023.09.12.23295357
History 
  • October 5, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Gustavo Arango-Argoty1,*,
  2. Elly Kipkogei1,
  3. Ross Stewart2,
  4. Arijit Patra3,
  5. Ioannis Kagiampakis1 and
  6. Etai Jacob1,*
  1. 1Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA
  2. 2Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK
  3. 3Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
  1. ↵*Co-corresponding authors: Gustavo Arango-Argoty, gustavo.arango{at}astrazeneca.com; Etai Jacob, etai.jacob{at}astrazeneca.com.
Back to top
Posted October 05, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers
Gustavo Arango-Argoty, Elly Kipkogei, Ross Stewart, Arijit Patra, Ioannis Kagiampakis, Etai Jacob
medRxiv 2023.09.12.23295357; doi: https://doi.org/10.1101/2023.09.12.23295357
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area